From New Mechanisms to New Standards of Care
Latest News
News / 17 Dec 2018
Proposed Subscription to Raise $25.0 million and Notice of General Meeting
News / 17 Dec 2018
Summit Therapeutics Announces Departure of Chief Financial Officer
News / 11 Dec 2018
Financial Results for the Third Quarter and Nine Months Ended 31 October 2018 and Operational Progress
We are building a very different antibiotics company that focuses on bringing innovation to antibiotic development. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.
Chief Executive Officer
For Investors
Visit our dedicated section for investors that contains the latest available financial and regulatory information
Latest Event
Listen to our sponsored KOL event on antibiotic stewardship hosted by Slingshot Insights
Our Discuva Platform
Our technology platform is at the heart of our research to develop new mechanism antibiotics